2026년 9월 13일•3분 읽기
Celltrion Pharm’s Bio and CMO Sales Surpass Chemical Segment, Reaching 54% in H1
Celltrion Pharm’s bio‑pharma and contract‑manufacturing sales now exceed half of total revenue, narrowing the gap with its traditional chemical drugs.